392 related articles for article (PubMed ID: 27606831)
1. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.
Ghali JR; Alikhan MA; Holdsworth SR; Kitching AR
Immunology; 2017 Jan; 150(1):100-114. PubMed ID: 27606831
[TBL] [Abstract][Full Text] [Related]
2. RORγt expression in T
Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
[TBL] [Abstract][Full Text] [Related]
3. Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways.
Joetham A; Schedel M; O'Connor BP; Kim S; Takeda K; Abbott J; Gelfand EW
J Allergy Clin Immunol; 2017 Apr; 139(4):1331-1342. PubMed ID: 27542981
[TBL] [Abstract][Full Text] [Related]
4. Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice.
Kondo Y; Yao Z; Tahara M; Iizuka M; Yokosawa M; Kaneko S; Segawa S; Tsuboi H; Yoh K; Takahashi S; Matsumoto I; Sumida T
Arthritis Res Ther; 2015 Apr; 17(1):105. PubMed ID: 25928901
[TBL] [Abstract][Full Text] [Related]
5. In-vitro inhibition of IFNγ+ iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function.
Daniel V; Sadeghi M; Wang H; Opelz G
BMC Immunol; 2012 Aug; 13():47. PubMed ID: 22905732
[TBL] [Abstract][Full Text] [Related]
6. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
7. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
[TBL] [Abstract][Full Text] [Related]
8. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM
J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380
[TBL] [Abstract][Full Text] [Related]
9. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.
Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K
Front Immunol; 2018; 9():125. PubMed ID: 29456534
[TBL] [Abstract][Full Text] [Related]
10. Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17
Su Y; Wang Q; Yang B; Wu L; Cheng G; Kuang H
Clin Exp Immunol; 2017 Oct; 190(1):40-53. PubMed ID: 28617942
[TBL] [Abstract][Full Text] [Related]
11. Dichotomous response to transforming growth factor β after T cell receptor activation by naive CD4+ T cells from DBA/1 mice: enhanced retinoic acid receptor-related orphan nuclear receptor γt expression yet reduced FoxP3 expression.
Morita Y; Ismail DM; Elkon KB; Chu CQ
Arthritis Rheum; 2011 Jan; 63(1):118-26. PubMed ID: 20862680
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
13. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
14. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
[TBL] [Abstract][Full Text] [Related]
15. Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection.
Moore C; Tejon G; Fuentes C; Hidalgo Y; Bono MR; Maldonado P; Fernandez R; Wood KJ; Fierro JA; Rosemblatt M; Sauma D; Bushell A
Eur J Immunol; 2015 Feb; 45(2):452-63. PubMed ID: 25381698
[TBL] [Abstract][Full Text] [Related]
16. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta.
Selvaraj RK; Geiger TL
J Immunol; 2007 Jul; 179(2):11 p following 1390. PubMed ID: 17695668
[TBL] [Abstract][Full Text] [Related]
17. CD4(+)CD62L(+) central memory T cells can be converted to Foxp3(+) T cells.
Zhang X; Chang Li X; Xiao X; Sun R; Tian Z; Wei H
PLoS One; 2013; 8(10):e77322. PubMed ID: 24155942
[TBL] [Abstract][Full Text] [Related]
18. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.
Koenecke C; Czeloth N; Bubke A; Schmitz S; Kissenpfennig A; Malissen B; Huehn J; Ganser A; Förster R; Prinz I
Eur J Immunol; 2009 Nov; 39(11):3091-6. PubMed ID: 19750478
[TBL] [Abstract][Full Text] [Related]
19. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
[TBL] [Abstract][Full Text] [Related]
20. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
Sahin E; Sahin M
J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
